Stephen A. Murray
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Molecular Biology top 5%
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- Signaling Pathways in Disease
- Pluripotent Stem Cells Research
- Congenital heart defects research
Papers in
- Aging 2
-
- CRISPR and Genetic Engineering 14
- Congenital heart defects research 9
- Pluripotent Stem Cells Research 8
- RNA Research and Splicing 6
- Co-authors
- Thomas GridleyAlan R. BoobisNigel J. GooderhamGraham W. TaylorLeah Rae DonahueD. S. DaviesLing GuCaleb Heffner
- Journals
- Mammalian Genome (7 papers)PLoS ONE (7 papers)Carcinogenesis (6 papers)Journal of Mass Spectrometry (5 papers)Disease Models & Mechanisms (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Stephen A. Murray
116 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 138
- Cancer Research 535
- Molecular Biology 2.2k
- Pharmacology 207
- Oncology 624
- Genetics 584
Countries citing papers authored by Stephen A. Murray
This map shows the geographic impact of Stephen A. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Murray more than expected).
Fields of papers citing papers by Stephen A. Murray
This network shows the impact of papers produced by Stephen A. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Murray. The network helps show where Stephen A. Murray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen A. Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 85 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 2 | |
| 6 | 2020 | 13 | |
| 7 | 2018 | 7 | |
| 8 | 2018 | 38 | |
| 9 | 2017 | 27 | |
| 10 | 2015 | 2 | |
| 11 | 2012 | 52 | |
| 12 | 2006 | 4 | |
| 13 | 2005 | 152 | |
| 14 | Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis | 2002 | 1 |
| 15 | 1996 | 16 | |
| 16 | 1995 | 26 | |
| 17 | 1993 | 24 | |
| 18 | 1988 | 2 | |
| 19 | 1987 | 14 | |
| 20 | Studies on the metabolic fate of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in man [proceedings]. | 1977 | 4 |
About Stephen A. Murray
Stephen A. Murray is a scholar working on Aging, Molecular Biology, Genetics, Cancer Research and Spectroscopy, having authored 118 papers that have together received 3.8k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (14 papers), Analytical Chemistry and Chromatography (10 papers), Carcinogens and Genotoxicity Assessment (9 papers), Congenital heart defects research (9 papers), Pluripotent Stem Cells Research (8 papers), Craniofacial Disorders and Treatments (6 papers), RNA Research and Splicing (6 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Cancer Research (535 citations), Molecular Biology (2.2k citations), Pharmacology (207 citations), Oncology (624 citations) and Genetics (584 citations). Stephen A. Murray has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Thomas Gridley, Alan R. Boobis, Nigel J. Gooderham, Graham W. Taylor, Leah Rae Donahue, D. S. Davies, Ling Gu, Caleb Heffner, Hongwu Zheng and Anthony M. Lynch. Their work appears in journals such as Mammalian Genome, PLoS ONE, Carcinogenesis, Journal of Mass Spectrometry and Disease Models & Mechanisms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.